U.S. drug manufacturers import at least 80% of their active pharmaceutical ingredients with an every increasing share coming from China and India. We’ll discuss some of the new questions being raised about safety standards of these imports.


  • Marc Kaufman Reporter on the national desk of "The Washington Post"
  • Dr. Gilbert Ross Medical/Executive Director American Council on Science and Health
  • Caroline Loew SVP, Scientific and Regulatory Affairs, PhRMA
  • Dr. Sidney Wolfe Director of the Health Research Group at Public Citizen; editor of WorstPills.org
  • Sen. Charles Grassley (R-Iowa), ranking member of the Senate Finance Committee


comments powered by Disqus
Most Recent Shows

Revisiting The Decision To Drop The Bomb

Thursday, May 18 2023As President Biden's visit to Hiroshima dredges up memories of World War II, Diane talks to historian Evan Thomas about his new book, "Road to Surrender," the story of America's decision to drop the atomic bomb.